Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: MJ Hudson and Tandem see results ahead of views

Mon, 31st Jan 2022 22:07

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

KRM22 PLC - London-based technology and software investment company - Expects widened adjusted earnings before interest, tax, depreciation loss of GBP0.8 million loss from GBP300,000 in 2020. Says cost base increased in 2021 compared to the prior year due to the reinstatement of salaries in order to ensure retention of key staff, expand the global risk platform and the extension of the company's risk management products. This all resulted in lower revenue recognised and an increase in adjusted Ebitda loss compared to 2020 and overall results slightly lower than current market expectations, it says.

----------

Xpediator PLC - Braintree, Essex-based freight management services - Says trading for 2021 continued strongly across all three divisions. For 2021, expects revenue in excess of GBP300 million, up from GBP221 million in 2020 and adjusted pretax profit "well in excess" of GBP8.5 million, up from GBP7.2 million in 2020, in line with the upgraded guidance given in June.

----------

FireAngel Safety Technology Group PLC - Coventry-based home safety products maker - Expects 2021 sales of GBP42.8 million, up from GBP39.9 million in 2020 and underlying pretax loss GBP3.8 million, narrowed from GBP5.7 million. FireAngel says seeing an easing of supply chain challenges but may persist in first quarter.

----------

Tribal Group PLC - Bristol, England education software and services - Says following a good performance, it anticipates 2021 results to be in line with market expectations.

----------

Rosslyn Data Technologies PLC - Portsmouth, England cloud based enterprise data analytics platform - For six months to October 31, posts revenue of GBP3.1 million from GBP3.6 million last year and pretax loss GBP2.1 million, widened from GBP883,000 loss. "Rosslyn now finds itself with a new leadership team of experienced professionals from the software industry, who are charged with our next phase of execution. The combination of bringing together the customer and product as the central nervous system of our execution, and the relaunching of a new brand into the market we expect to give us a springboard into 2022 and beyond. We look to the future with increasing confidence," it says.

----------

Amala Foods PLC - Jersey-based food technology company - For six months to September 30, pretax loss narrows to GBP185,703 from GBP426,162. No dividends have been paid during the half-year.

----------

MJ Hudson Group PLC - London-based asset management consultancy - Says trading in the first quarter of financial 2022 has been strong, continuing momentum from the six months prior. For six months to December 31 says it has continued to perform well, winning multiple new clients, many of which are accessing multiple services. As a result of this strong performance, underlying revenue for the full year ending June 30 is now expected to be ahead of market expectations.

----------

Journeo PLC - Leicestershire-based transport information systems and technical services - Says strategy of developing technologies, IP and information services centred around customers in public and freight transport applications, led to a increase in order intake during 2021. Says revenue increased by 15% in 2021 to GBP15.6 million from GBP13.6 million in 2020. Due to the type of work completed and the varying margins involved, profit for the full year is anticipated to be in line with market expectations, it adds.

----------

Engage XR Holdings PLC - Waterford City, Ireland-based virtual communications solutions - Expects 2021 revenue of EUR2.4 million, up 68% on the prior year's EUR1.4 million. Also says Non-Executive Director Frank Poore resigned from board with immediate effect to focus on other business interests.

----------

STM Group PLC - Isle of Man-based pensions and insurance administrator - Says trading results for 2021 will be materially in line with previous guidance and expectations for 2022 also remain in line with existing guidance.

----------

BATM Advanced Communications Ltd - Israel-based networking technology and medical lab systems - Has invested an additional USD10 million in Ador Diagnostics.

----------

Tandem Group PLC - sports equipment distributor based in West Midlands - Says Christmas trading period saw continued robust performance from the group's toys, sports & leisure business. Notes the rate of growth achieved in the second half of 2021 did not match the levels seen in first half, turnover was still over 7% ahead of the same period in the prior year, despite the ongoing logistics impacts. As a result, expects to report 2021 revenue of GBP40.9 million, with pretax profit expected to be well ahead of the prior year and slightly ahead of the current market expectations. Says 2022 has begun more slowly, with some customers delaying orders into future months. However, it remains confident that we have secured the strongest wheeled toy licences and have some exciting developments planned for the year.

----------

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Says first patient dosed with second COVIDITY vaccine candidate and preclinical studies demonstrate strong immunity against Omicron.

----------

Inland ZDP PLC - wholly-owned subsidiary of housing plot developer Inland Homes PLC - Reports asset value per ZDP share 176.86 pence at September 30, up from 167.30p a year ago.

----------

Quantum Exponential Group PLC - quantum technology investment firm - Says it has held discussions with a number of potential investee companies, several of which are being actively pursued. Quantum Exponential says Chief Operating Office Steven Metcalfe to become CEO.

----------

San Leon Energy PLC - oil and gas production, development and exploration company focused on Nigeria - Says two of its subsidiaries have successfully concluded ongoing legal proceedings with TAQA Offshore BV in relation to San Leon's legacy interests in two royalties on Block Q13A. Says it has now received payments of more than EUR5.7 million, including an interim payment in respect of legal costs.

----------

Gunsynd PLC - UK-based investment company - Sells 600,000 shares in Charger Metals Ltd for 82 Australian cents for proceeds of AUD493,000 - around GBP260,000. Following this disposal, Gunsynd continues to hold 3 million shares in Charger representing approximately 6%.

----------

Hummingbird Resources PLC - gold miner with projects in Mali, Liberia and Guinea - Reports 18,181 ounces of gold poured at Yanfolila mine in Mali. Says 2021 production of 87,558 ounces, in line with the revised guidance range of 84,000 to 89,000 punces. Looking ahead, guides for 2022 production guidance of 87,000 to 97,000 ounces of gold, with an AISC of USD1,300 to 1,450 per ounce of gold. First quarter forecast to be a lower production quarter versus the remaining quarters of 2022 driven primarily by an additional five excavators becoming increasingly operational.

----------

MGC Pharmaceuticals Ltd - European based company specialising in the production and development of phytomedicine - Sees strongest quarterly sales in three months to December 31, with product sales totalling USD1.8 million, including continued strong sales growth from the phytocannabinoid medicine line of products.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
1 Sep 2022 17:52

TRADING UPDATES: Strong interim results from Johnson Service, Eurocell

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Aug 2022 11:57

IN BRIEF: Graft Polymer wins first commercial order for GraftBio

Graft Polymer (UK) PLC - London-based company focused on the development and production of polymer modification, biological supplements, and nano-drug delivery systems - Wins first commercial purchase order for its GraftBio division. Order for 50,000 units of its anti-inflammatory supplement, ArtemiC Rescue from MGC Pharmaceuticals PLC. Order worth around USD1 million. Production to start immediately. Delivery expected over the next three months. Chief Executive Victor Volduev says he expects follow-on orders in the coming quarters.

Read more
17 Aug 2022 11:12

MGC shares rise on USD1 million order for ArtemiC

(Alliance News) - MGC Pharmaceuticals Ltd shares were lifted on Wednesday after it announced a USD1 million order for its neutraceutical, ArtemiC.

Read more
15 Aug 2022 17:31

IN BRIEF: MGC Pharma's CannEpil found safe for driving in study

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says clinical study results for its epilepsy treatment, CannEpil, are complete. The study found CannEpil to be safe for post-treatment driving activities. It used a driving simulator to test whether the drug caused somnolence, ie drowsiness, or impairs cognition. It was sponsored by Cannvalate Australia, and conducted by the Centre of Human Psychopharmacology at Swinburne University of Technology, under the Medical Cannabis Research Collaboration.

Read more
5 Aug 2022 14:58

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

Read more
29 Jul 2022 19:36

TRADING UPDATES: Walker Crips assets grow; Minoan interim loss narrows

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Jul 2022 20:08

TRADING UPDATES: Scottish American outperforms; Amte picks Dundee

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Jul 2022 21:53

IN BRIEF: MGC Pharmaceuticals quarterly sales "strong"

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says "strong" quarterly sales continue, notes AUD1.6 million, about GBP923,000, in cash receipts during three month period to June 30. In 12-month period, records AUD6.1 million in cash receipts.

Read more
14 Jul 2022 21:44

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
8 Jul 2022 14:19

IN BRIEF: MGC Pharmaceuticals wins approval for Covid study, shares up

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Receives approval from South African Health Products Regulatory Authority for a Phase 2b dose finding study of its nanoparticle formulation CimetrA on patients diagnosed with Covid-19.

Read more
6 Jul 2022 20:08

IN BRIEF: MGC Pharmaceuticals launches medical data app ZAM

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says it is set to launch a real-time data collection application, ZAM, for use across the pharmaceutical and health care sectors, in collaboration with software development company, Caba Tech. The app will be available during the third quarter and will enable patients to log their medical history and monitor their medication use. ZAM, through the collection the patient data, will also provide users with a more complete understanding of their health and treatments, it says.

Read more
27 Jun 2022 20:27

IN BRIEF: MGC's CimetrA shows promise beyond Covid applications

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says preliminary results from pre-clinical in vitro study of CimetrA show it could have "wide-ranging application" as anti-inflammatory treatment. This is through the treatment's modulation of the production of pro-inflammatory cytokines. The study was undertaken by Israeli contract research organisation, Science in Action. Results support previous findings from a 2020 study into Covid-19, which showed CimetrA modulates the body's production of cytokines, which can lead to a cytokine storm, a type of severe immune reaction. New results support the potential of CimetrA to have a wider-ranging application as anti-inflammatory treatment, beyond the treatment of Covid-19 symptoms.

Read more
24 Jun 2022 10:13

IN BRIEF: MGC Pharma moves ahead with Covid-19 treatment in US

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Progresses plans to begin US clinical trial for its Covid-19 treatment CimetrA, as MGC and AMC Holdings Inc executives meet with department heads from the University of South Florida. Parties also discuss regulatory approvals for phytocannabinoid medicines CogniCann and CannEpil in the US for early patient access schemes. Says US market access and distribution agreement has been signed with minimum orders of USD24 million over three years, including CimetrA.

Read more
16 Jun 2022 13:43

IN BRIEF: MGC Pharmaceuticals completes research study on brain cancer

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Completes an in-vitro preclinical research study with the National Institute of Biology into the use of cannabinoids to treat brain cancer. The company says the study, undertaken on 30 biopsy samples from 18 patients over a period of three years, sought to determine the optimal formulation for the treatment of Glioblastoma, a form of brain cancer. The study showed that MGC Pharma's proprietary formulations were cytotoxic to Glioblastoma tumour and stem cells, reducing the cells' viability and inducing caspase-dependent cell apoptosis, or cell death.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.